LLY - ProMIS Neuro draws Buy at BTIG on lead Alzheimer's asset
2023-10-03 13:53:21 ET
More on ProMIS Neurosciences
- ProMIS Neurosciences scales 31% on $20.4M private placement
- ProMIS stock rockets 115% amid preclinical data for Alzheimer's drug
- Historical earnings data for ProMIS Neurosciences
- Financial information for ProMIS Neurosciences
For further details see:
ProMIS Neuro draws Buy at BTIG on lead Alzheimer’s asset